Tradestie Institutional Equity Comparison Engine
VNDA vs RIGL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RIGL Overall Edge
RIGL Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Rigel Pharmaceuticals Inc. (New) (RIGL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VNDA trades at 103.1x Forward P/E with -77.6% operating margin (+24.1% YoY revenue) versus RIGL at 9.3x Forward P/E and 26.3% operating margin (+16.5% YoY). In options structure, VNDA sits in BREAKDOWN (75th %ile IV; Dealer Gamma Walls on Pro) against RIGL sits in CONSOLIDATION (4th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
RIGL
VNDA 103.1x vs RIGL 9.3x Fwd P/E
Growth & Margin Winner
RIGL
Op Margin -77.6% vs 26.3% ยท YoY +24.1% vs +16.5%
Momentum & Technical Winner
RIGL
1Y -12.6% vs +9.7% ยท 52W Pos 4% vs 68%
Options & Structure Winner
RIGL
BREAKDOWN (75th %ile IV) vs CONSOLIDATION (4th %ile IV)
VNDA
NASDAQ
Vanda Pharmaceuticals Inc.
Pharmaceutical Preparations
$3.79
-4.89% 1D
Market Cap
$238.9M
1M Return
-5.83%
1Y Return
-12.56%
Forward P/E
103.1x
Unified AI Score
49.0 / 100
HOLD
Tech 56.0
Fund 58.0
Flow 65.0
Mom 64.0
RIGL
NASDAQ
Rigel Pharmaceuticals Inc. (New)
Pharmaceutical Preparations
$43.74
-1.61% 1D
Market Cap
$860.3M
1M Return
-4.84%
1Y Return
+9.69%
Forward P/E
9.3x
Unified AI Score
59.9 / 100
HOLD
Tech 48.0
Fund 58.0
Flow 68.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
VNDA -12.56%
RIGL +9.69%
Spread: +22.25 pp (RIGL Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VNDA Revenue | RIGL Revenue | VNDA Op. Margin | RIGL Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $190M | $40M | 11.3% | -163.3% | VNDA |
| FY2019 | $230M | $60M | 10.0% | -116.5% | VNDA |
| FY2020 | $250M | $110M | 11.0% | -26.7% | VNDA |
| FY2021 | $270M | $150M | 15.7% | -8.4% | VNDA |
| FY2022 | $250M | $120M | 2.5% | -46.2% | VNDA |
| FY2023 | $190M | $120M | -7.2% | -17.5% | VNDA |
| FY2024 | $200M | $180M | -20.5% | 13.5% | RIGL |
| FY2025 | $220M | $290M | -70.0% | 42.6% | RIGL |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VNDA | RIGL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $238.9M | $860.3M | Larger Scale | RIGL |
| Trailing P/E Ratio Valuation | 103.1x | 2.8x | Lower Multiple | RIGL |
| Forward P/E Ratio Valuation | 103.1x | 9.3x | Lower Multiple | RIGL |
| Revenue Growth (YoY) Growth | +24.1% | +16.5% | Higher Growth | VNDA |
| Operating Margin (TTM) Profitability | -77.6% | 26.3% | Higher Margin | RIGL |
| Net Profit Margin Profitability | -119.9% | 106.6% | Higher Margin | RIGL |
| Return on Equity (ROE) Capital Efficiency | -82.5% | 109.2% | Higher ROE | RIGL |
| 52-Week Range Position Momentum | 4% ($4โ$10) | 68% ($25โ$53) | Stronger Trend | RIGL |
| Beta / 30D Volatility Risk Regime | 1.25ฮฒ ยท 61% Vol | 1.06ฮฒ ยท 74% Vol | Lower Realized Risk | VNDA |
| Unified Institutional Score Composite Signal | 49.0 / 100 (HOLD) | 59.9 / 100 (HOLD) | Higher Composite | RIGL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full VNDA vs RIGL Buy Guide
VNDA
BREAKDOWN
174d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
75th %ile
IV Regime
Elevated (60thโ80th %ile)
RIGL
CONSOLIDATION
91d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
4th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither VNDA nor RIGL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.